Xsphera Biosciences Inc
Biotechnology ResearchMassachusetts, United States11-50 Employees
Xsphera Biosciences Inc. is a biotechnology research company based in Cambridge, Massachusetts. It has developed an ex vivo platform that uses human tumor tissue to evaluate responses to cancer therapies in controlled conditions, aiming to improve the predictive relevance of preclinical testing for human patients. The approach seeks to capture the tumor microenvironment and measure how different treatments influence tumor cells and immune activity within a clinical context. The platform brings together tissue, patient, and result data in a single cloud-based system, where AI-assisted analysis interprets complex multi-omic response data to generate actionable insights. Its primary customers are oncology drug developers and clinical teams seeking to de-risk programs and deepen understanding of why therapies succeed or fail. In a recent development, the company announced a collaboration with Dana-Farber Cancer Institute to advance its platform using fresh human tumor tissue to assess therapeutic efficacy across cancer indications.